Mt. Sinai Identifies First Drug to Demonstrate Therapeutic Effect in a Type of Autism

Source: 
EurekAlert
Date Published: 
May 20, 2010
Abstract: 

Researchers from Mount Sinai School of Medicine have identified a drug that improves communication between nerve cells in a mouse model of Phelan-McDermid Syndrome (PMS). Behavioral symptoms of PMS fall under the autism spectrum disorder category.